Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „posaconazole“
Suchtreffer
Begriffe & Kennungen
Noxafil · 4.5 · Venetoclax Compared with venetoclax 400 mg administered alone, co-administration of 300 mg posaconazole, a str
Eintrag öffnenNoxafil · 4.5 · Venetoclax Compared with venetoclax 400 mg administered alone, co-administration of 300 mg posaconazole, a str
Eintrag öffnenNoxafil · 4.5 · Venetoclax Compared with venetoclax 400 mg administered alone, co-administration of 300 mg posaconazole, a str
Eintrag öffnenNoxafil · 4.8 · 52 QTc prolongation QTc prolongation has been reported with the use of posaconazole (see section 4.4).
Eintrag öffnenNoxafil · 4.8 · In initial studies of healthy volunteers, administration of a single dose of posaconazole infused over 30 minu
Eintrag öffnenNoxafil · 4.8 · Infusion-related reactions During intravenous administration of posaconazole, infusion-related reactions inclu
Eintrag öffnenNoxafil · 4.8 · Paediatric population The safety of posaconazole concentrate for solution for infusion, posaconazole gastro-re
Eintrag öffnenNoxafil · 4.8 · Paediatric population The safety of posaconazole concentrate for solution for infusion, posaconazole tablets,
Eintrag öffnenNoxafil · 4.8 · Paediatric population The safety of posaconazole tablets, posaconazole concentrate for solution for infusion,
Eintrag öffnenNoxafil · 4.8 · QTc prolongation QTc prolongation has been reported with the use of posaconazole (see section 4.4).
Eintrag öffnenNoxafil · 4.8 · QTc prolongation QTc prolongation has been reported with the use of posaconazole (see section 4.4).
Eintrag öffnenNoxafil · 4.8 · QTc prolongation QTc prolongation has been reported with the use of posaconazole (see section 4.4).
Eintrag öffnenNoxafil · 4.8 · The most frequently reported adverse reaction (> 25 %) with an onset during the posaconazole intravenous phase
Eintrag öffnenNoxafil · 4.8 · The most frequently reported adverse reaction leading to discontinuation of posaconazole tablets was nausea.
Eintrag öffnenNoxafil · 4.8 · The most frequently reported adverse reactions for patients treated with posaconazole concentrate for solution
Eintrag öffnenNoxafil · 4.8 · The most frequently reported adverse reactions leading to discontinuation of posaconazole concentrate for solu
Eintrag öffnenNoxafil · 4.8 · The most frequently reported treatment-related adverse reactions (5%) with posaconazole tablets were nausea an
Eintrag öffnenPlenadren · 4.5 · Potent CYP 3A4 inhibitors such as ketoconazole, itraconazole, posaconazole, voriconazole erythromycin, telithr
Eintrag öffnenPosaconazole AHCL
Eintrag öffnenPosaconazole AHCL · 4.1 Therapeutic indications · 1
Eintrag öffnen